Picture of Camurus AB logo

CAMX — Camurus AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeLarge CapHigh Flyer

Brief: Camurus Q2 EBIT Turns To Profit At SEK 7 Million

July 15 (Reuters) - Camurus AB  CAMX.ST :
    * Q2 TOTAL REVENUES AMOUNTED TO SEK 227 (138) MILLION
    * Q2 OPERATING RESULT WAS SEK 7 (-60) MILLION
    * OUR POSITIVE DEVELOPMENT CONTINUED DURING Q2 WITH
INCREASING
BUVIDAL PATIENT NUMBERS, IMPROVED FINANCIAL RESULT, AND PROGRESS
IN OUR REGISTRATION AND PHASE 3 PROGRAMS IN CHRONIC PAIN AND
RARE DISEASES
    * STRONG, DOUBLE-DIGIT GROWTH OF BUVIDAL SALES RESULTED IN A
HISTORIC FIRST PROFITABLE QUARTER, IMPROVED CASH POSITION, AND A
RAISED FULL-YEAR RESULT GUIDANCE
    * WE ARE WELL POSITIONED TO SUCCESSFULLY DELIVER ON OUR
GOALS FOR
YEAR AND LONG-TERM STRATEGY

Source text for Eikon:  ID:nWkr3K90tc 
Further company coverage:  CAMX.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Camurus AB

See all news